APA

Turka L. A., Linsley P. S., Lin H., Brady W., Leiden J. M., Wei R. Q., Gibson M. L., Zheng X. G., Myrdal S. & Gordon D. (19921223). T-cell activation by the CD28 ligand B7 is required for cardiac allograft rejection in vivo. : Proceedings of the National Academy of Sciences of the United States of America.

Chicago

Turka L A, Linsley P S, Lin H, Brady W, Leiden J M, Wei R Q, Gibson M L, Zheng X G, Myrdal S and Gordon D. 19921223. T-cell activation by the CD28 ligand B7 is required for cardiac allograft rejection in vivo. : Proceedings of the National Academy of Sciences of the United States of America.

Harvard

Turka L. A., Linsley P. S., Lin H., Brady W., Leiden J. M., Wei R. Q., Gibson M. L., Zheng X. G., Myrdal S. and Gordon D. (19921223). T-cell activation by the CD28 ligand B7 is required for cardiac allograft rejection in vivo. : Proceedings of the National Academy of Sciences of the United States of America.

MLA

Turka L A, Linsley P S, Lin H, Brady W, Leiden J M, Wei R Q, Gibson M L, Zheng X G, Myrdal S and Gordon D. T-cell activation by the CD28 ligand B7 is required for cardiac allograft rejection in vivo. : Proceedings of the National Academy of Sciences of the United States of America. 19921223.